Biuckians Andre, Scott Eric C, Meier George H, Panneton Jean M, Glickman Marc H
Division of Vascular Surgery, Eastern Virginia Medical School, Norfolk, VA 23507, USA.
J Vasc Surg. 2008 Feb;47(2):415-21; discussion 420-1. doi: 10.1016/j.jvs.2007.10.041.
Patients on hemodialysis depend on durable, easily maintained vascular access. The autologous arteriovenous fistula (AVF) has been the gold standard since the introduction of the Brecia-Cimino fistula in 1966 and is echoed in the current Kidney Disease Outcomes and Quality Initiative (KDOQI) guidelines. The purpose of this study is to determine the natural history of AVF in patients requiring first-time permanent access in a large academic vascular surgery practice.
We performed a retrospective review of patients undergoing new access creation from January 1, 2005 to June 30, 2005. The study group consisted of patients with no prior permanent access that underwent AVF creation. Categorical data was compared using chi2 analysis, nominal data was compared using Student t-test, and patency was determined by Kaplan-Meier curves.
During the 6-month period, there were 80 first time AVF creations. The majority of patients were male (69%), African American (55%), and a history of diabetes (55%) and hypertension (96%). Seventy-five percent of patients were already undergoing hemodialysis via catheter access. Seventy-six percent of patients underwent preoperative vein mapping with a mean vein diameter of 3.1 mm. Twenty-six radiocephalic AVF (RCAVF) and 54 brachiocephalic AVF (BCAVF) were created with a mean follow-up of 278 days. At the end of follow-up, 38 (48%) AVF were being used for hemodialysis and only nine (11%) matured without the need for additional intervention. Mean time for AVF maturation was 146 days. Thirty AVF (37%) were abandoned, 16 (20%) of which were primary failures. Mean time to abandonment was 162 days. Twelve (15%) AVF remained patent but were never cannulated. The intervention rate was 1.33 interventions/patient/year and 75% of interventions were percutaneous. Kaplan-Meier analysis determined primary, primary-assisted, and secondary patency was 36% +/- 8.3, 55% +/- 6.5, and 55% +/- 6.5 at 1 year, respectively. Cumulative functional patency was 63% at 1 year.
In patients receiving a first time permanent access, we found that the majority were AVF and they resulted in low primary patency rates at 1 year and long maturation times. KDOQI encourages AVF creation in order to increase AVF use for dialysis, but the strategy of simply increasing the number being created may not lead to the desired result and potentially lead to an increase in catheter dependence.
接受血液透析的患者依赖耐用且易于维护的血管通路。自1966年布雷西亚 - 奇米诺动静脉内瘘问世以来,自体动静脉内瘘(AVF)一直是金标准,当前的《肾脏病预后质量倡议》(KDOQI)指南也对此予以呼应。本研究的目的是确定在大型学术性血管外科实践中首次需要永久性血管通路的患者中AVF的自然病程。
我们对2005年1月1日至2005年6月30日期间接受新血管通路建立的患者进行了回顾性研究。研究组由之前未进行过永久性血管通路建立且接受AVF创建的患者组成。分类数据采用卡方分析进行比较,名义数据采用学生t检验进行比较,通畅率通过Kaplan - Meier曲线确定。
在这6个月期间,共进行了80例首次AVF创建。大多数患者为男性(69%)、非裔美国人(55%),有糖尿病史(55%)和高血压史(96%)。75%的患者已通过导管通路进行血液透析。76%的患者进行了术前静脉造影,平均静脉直径为3.1毫米。创建了26例桡动脉 - 头静脉内瘘(RCAVF)和54例肱动脉 - 头静脉内瘘(BCAVF),平均随访278天。随访结束时,38例(48%)AVF用于血液透析,只有9例(11%)成熟且无需额外干预。AVF成熟的平均时间为146天。30例AVF(37%)被废弃,其中16例(20%)为原发性失败。废弃的平均时间为162天。12例(15%)AVF保持通畅但从未进行过穿刺。干预率为1.33次干预/患者/年,75%的干预为经皮干预。Kaplan - Meier分析确定1年时的原发性、原发性辅助性和继发性通畅率分别为36%±8.3、55%±6.5和55%±6.5。1年时的累积功能通畅率为63%。
在首次接受永久性血管通路的患者中,我们发现大多数为AVF,但1年时原发性通畅率较低且成熟时间较长。KDOQI鼓励创建AVF以增加其在透析中的使用,但单纯增加创建数量的策略可能无法达到预期效果,反而可能导致对导管依赖的增加。